Cause of death, by non-communicable diseases, ages 15-59 in Albania
Albania: Cause of death, by non-communicable diseases, ages 15-59 was 45.1% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 15-59 in Albania, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59 in Albania stood at 45.1%. That is the lowest value across all 6 years on record.
That represents a change of down 21.7% on the previous year and down 39.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Albania peaked at 77.2% in 2019 and was at its lowest, 45.1%, in 2021.
Albania ranks 129th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59 in Albania, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 66.2% | — |
| 2010 | 74.5% | +12.5% |
| 2015 | 77.1% | +3.4% |
| 2019 | 77.2% | +0.1% |
| 2020 | 57.6% | -25.4% |
| 2021 | 45.1% | -21.7% |
Albania compared with similar countries
- Albania's 45.1% is below the median for upper middle income countries, which is 53.8%, 84% of the median. (55 countries reporting)
- Albania's 45.1% is below the median for Europe & Central Asia, which is 68.4%, 66% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 66.2% | 66.2% | 66.2% | 1 |
| 2010s | 76.3% | 74.5% | 77.2% | 3 |
| 2020s | 51.3% | 45.1% | 57.6% | 2 |
Countries ranked near Albania
More health data for Albania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.287 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,085 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.99 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.024 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.15 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Albania?
- Cause of death, by non-communicable diseases, ages 15-59 in Albania was 45.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Albania?
- The highest recorded value was 77.2% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Albania?
- The lowest recorded value was 45.1% in 2021.
- How does Albania rank for cause of death, by non-communicable diseases, ages 15-59?
- Albania ranks 129th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Albania?
- Over the last ten years it is down 39.5%. The long-run trend across the full record is falling.
- Where does this Albania data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.